Iron Deficiency Anemia Treatments
Recommendations for the management of iron deficiency anemia including oral and intravenous iron therapies.
Recommendations for the management of iron deficiency anemia including oral and intravenous iron therapies.
A comparative list of biosimilars approved by the FDA including their reference products, dosage forms and indications.
Treatment options for von Willebrand Disease (VWD).
Risk factors, prevention strategies, signs & symptoms, and general treatment options for deep vein thrombosis (DVT) and pulmonary embolism (PE).
Recommended dosing conversions for anticoagulants such as warfarin, heparin, and dabigatran.
Eflapegrastim is a novel, long-acting G-CSF comprised of 2 protein components, an analogue of G-CSF and an Fc antibody fragment.
Anticoagulants, antiplatelets, and thrombolytics for the treatment and/or prophylaxis of venous and arterial thrombosis.
Treatment options for Hemophilia A including factors and other biologics.
These guidelines from ASH, ISTH, NHF, and WFH are intended to support patients, clinicians, and healthcare professionals in their decisions affecting the management of VWD.